{"id":"W2980928034","doi":"10.1007/s00198-019-05146-9","title":"Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab","year":2019,"lang":"en","type":"article","venue":"Osteoporosis International","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Shionogi; UCB Pharma; Astellas Pharma; Gedeon Richter; Atara Biotherapeutics; Servier; Amgen; Pfizer; Teva Pharmaceutical Industries; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Denosumab; Bone mineral; Internal medicine; Placebo; Rheumatology; Bone Density Conservation Agents; Osteoporosis; Oncology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009139068,0.0006574212,0.001951042,0.0003846998,0.0003128424,0.0003751023,0.0004148856,0.0009545847,0.004343465],"category_scores_gemma":[0.000750314,0.000299348,0.0008219829,0.0001987781,0.0003372101,0.0004219826,0.0003006479,0.001836238,0.0007536407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002970828,"about_ca_system_score_gemma":0.0004511876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005240131,"about_ca_topic_score_gemma":0.0008915858,"domain_scores_codex":[0.9995589,0.0001178829,0.00004253917,0.000113712,0.00007208778,0.00009485344],"domain_scores_gemma":[0.999534,0.00009509009,0.0001366317,0.00006368371,0.00003570422,0.0001348428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7682452,0.05737476,0.009591591,0.0004226839,0.0006585128,0.0001264903,0.0001665683,0.0005025368,0.06170006,0.00008053319,0.0008969111,0.1002342],"study_design_scores_gemma":[0.1302961,0.8040066,0.04322127,0.0000345787,0.0004238847,0.0002688964,0.00004597284,0.0005066346,0.01888961,0.0001005536,0.002179771,0.00002615021],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969923,0.000659495,0.0002661926,0.00007586315,0.00007757862,0.0008296127,0.0002886901,0.00005259715,0.0007575377],"genre_scores_gemma":[0.9945003,0.0003227076,0.0009264011,0.0001620784,0.00009609361,0.001193302,0.000475401,0.00000778421,0.00231598],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004343465,"threshold_uncertainty_score":0.0145303,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02734819200415372,"score_gpt":0.3253009263613552,"score_spread":0.2979527343572015,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}